Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | BCL11A |
| Upstream (Parents) |
|---|
| (<<) FOXC1 → BCL11A |
| (<<) CYP4Z2P → BCL11A |
| Downstream (Children) |
|---|
| BCL11A → THNSL1 (>>) |
| BCL11A → NCOA7 (>>) |
| BCL11A → OXCT1 (>>) |
| BCL11A → IGSF21 (>>) |
| BCL11A → RBM17 (>>) |
| BCL11A → GPM6B (>>) |
| BCL11A → ART3 (>>) |
| BCL11A → CA12 (>>) |
| BCL11A → CYP4F8 (>>) |
| BCL11A → MFSD4 (>>) |
| BCL11A → KIT (>>) |
| BCL11A → CDC20B (>>) |
| BCL11A → NEK6 (>>) |
| BCL11A → ADSSL1 (>>) |
| BCL11A → DUSP10 (>>) |
| BCL11A → TANC2 (>>) |
| BCL11A → ACTR3B (>>) |
| BCL11A → ITGA9 (>>) |
| BCL11A → CACNG4 (>>) |
| BCL11A → ST8SIA1 (>>) |
| BCL11A → TBC1D4 (>>) |
| BCL11A → DMD (>>) |
